𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic polymorphism and Parkinson's disease in Taiwan: Study of debrisoquine 4-hydroxylase (CYP2D6)

✍ Scribed by Hsiao-Sui Lo; Chia-Hsiang Chen; Edward L Hogan; Ko-Pei Kao; Vinchi Wang; Sui-Hing Yan

Book ID
119469988
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
60 KB
Volume
158
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CYP2D6 polymorphism in Parkinson's disea
CYP2D6 polymorphism in Parkinson's disease: The Rotterdam study
✍ B. Sanjay Harhangi; Ben A. Oostra; Peter Heutink; Cornelia M. van Duijn; Albert πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 26 KB

## Abstract The CYP2D6 polymorphism has been studied extensively in association with Parkinson's disease (PD), with no consistent results. Several explanations, such as differences in study design or bias in the selection of the control population, have been offered for these inconsistent results.

Rarity of debrisoquine hydroxylase gene
Rarity of debrisoquine hydroxylase gene polymorphism in chinese patients with Parkinson's disease
✍ Dr. Chi P. Pang; Jun Zhang; Jean Woo; Daniel Chan; Lap K. Law; Shirley F. Tong; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 415 KB

## Abstract Impaired debrisoquine metabolism resulting from defects in the cytochrome P450 __CYP2D6__‐debrisoquine hydroxylase gene has been shown to be associated with the development of Parkinson's disease(PD). We studied two polymorphisms in this gene in 207 Chinese PD patients and 227 control s